Fund
Wellington Management
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 2
- Lead
- 1
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 20 February 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 20 Feb | United States, Biotech | Series A | 175 M$ | Lead |
| 06 Feb | United States, Biotech | Series D and later | 130 M$ | Participant |
Co investors 13 funds crossed
- Venrock Healthcare Capital Partners 2 operations
- Ascenta Capital 1 operation
- Bain Capital Life Sciences 1 operation
- BlackRock 1 operation
- BVF Partners 1 operation
- Fairmount 1 operation
- Frazier Life Sciences 1 operation
- Hillhouse Investment 1 operation
- Logos Capital 1 operation
- OrbiMed 1 operation
- Paragon Therapeutics 1 operation
- RA Capital Management 1 operation
- TCGX 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.